FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2252383830> ?p ?o ?g. }

• W2252383830 endingPage "342" @default.
• W2252383830 startingPage "333" @default.
• W2252383830 abstract "BACKGROUND: Systemic inflammation has been implicated in cancer development and progression. The aim of the present study was to evaluate whether pre-operative systemic inflammatory markers can predict outcomes in bone and soft tissue sarcomas. METHODS: Relevant literature was mainly identified usi ng Pubmed, EMBASE and CNKI. Patients' clinical characteristics, overall survival (OS), disease/relapse free survival (DFS/RFS) with high-level CRP or neutrophils to lymphocytes ratio (NLR) were extracted. The statistics extracted from Kaplan-Meier survival curves with log-rank p value were calculated with methods developed by Parmar, Williamson, and Tierney; multivariate Cox hazard regression analysis data were used directly in STATA 10.0. Pooled hazard ratio (HR) and 95% CI were calculated to evaluate the prognostic role of these systemic inflammatory markers (CRP/NLR). RESULTS: After full text review, 11 articles containing 1809 patients were identified as eligible articles. The meta-analysis for survival outcome showed significant prognostic value of systemic inflammatory markers including CRP and NLR in pre-operative blood. The combined HRs (95% CI) for five year overall survival (OS) and disease/recurrence free survival (DFS/RFS) were 2.54 [2.04, 3.16] and 2.28 [1.72, 3.04]. Specifically, higher NLR was associated with decreased 5-year OS (HR 3.75, 95% CI 1.24 to 11.37) and 3 year RFS/DFS (HR 2.43, 95% CI 0.84 to 7.05). Besides, the pooled HR showed a higher risk of 5-year disease progression (HR 2.55, 95% CI 1.60 to 4.08, I2 = 52%) and lower 5-year OS (HR 2.50, 95% CI 2.00 to 3.12, I2 = 0%) in sarcoma patients with high CRP level. We then grouped the meta-analysis by patient source (Asian and non-Asian), tumor stage (I/II or III/IV) and grade (high or low), respectively. All the subgroup analysis showed significant prognostic role in survival condition. The CRP/NLR levels are also found closely related with patient age, tumor stage and size. CONCLUSION: Higher level of pre-operative CRP and NLR demonstrated a significantly higher risk of recurrence and overall decreased survival rates in sarcomas." @default.
• W2252383830 created "2016-06-24" @default.
• W2252383830 creator A5003866201 @default.
• W2252383830 creator A5007553862 @default.
• W2252383830 creator A5062225954 @default.
• W2252383830 creator A5072844265 @default.
• W2252383830 date "2016-03-30" @default.
• W2252383830 modified "2023-10-17" @default.
• W2252383830 title "Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma" @default.
• W2252383830 cites W1521470944 @default.
• W2252383830 cites W1555149814 @default.
• W2252383830 cites W1965037168 @default.
• W2252383830 cites W1966258445 @default.
• W2252383830 cites W1966762476 @default.
• W2252383830 cites W1970521189 @default.
• W2252383830 cites W1981187546 @default.
• W2252383830 cites W1988147915 @default.
• W2252383830 cites W1988968354 @default.
• W2252383830 cites W1991015084 @default.
• W2252383830 cites W1993133962 @default.
• W2252383830 cites W1993310990 @default.
• W2252383830 cites W1993867849 @default.
• W2252383830 cites W1996588196 @default.
• W2252383830 cites W1997114025 @default.
• W2252383830 cites W1997923405 @default.
• W2252383830 cites W2004134411 @default.
• W2252383830 cites W2035632263 @default.
• W2252383830 cites W2042371400 @default.
• W2252383830 cites W2046552752 @default.
• W2252383830 cites W2047415855 @default.
• W2252383830 cites W2053545935 @default.
• W2252383830 cites W2053546660 @default.
• W2252383830 cites W2053953412 @default.
• W2252383830 cites W2054281553 @default.
• W2252383830 cites W2059107101 @default.
• W2252383830 cites W2066834038 @default.
• W2252383830 cites W2071136530 @default.
• W2252383830 cites W2075642745 @default.
• W2252383830 cites W2077237731 @default.
• W2252383830 cites W2088095316 @default.
• W2252383830 cites W2095316759 @default.
• W2252383830 cites W2097429991 @default.
• W2252383830 cites W2097608507 @default.
• W2252383830 cites W2116554142 @default.
• W2252383830 cites W2125435699 @default.
• W2252383830 cites W2140910532 @default.
• W2252383830 cites W2159276455 @default.
• W2252383830 cites W2167409896 @default.
• W2252383830 cites W2170189012 @default.
• W2252383830 cites W2172355816 @default.
• W2252383830 cites W237404453 @default.
• W2252383830 cites W4211207176 @default.
• W2252383830 doi "https://doi.org/10.3233/cbm-160571" @default.
• W2252383830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26835589" @default.
• W2252383830 hasPublicationYear "2016" @default.
• W2252383830 type Work @default.
• W2252383830 sameAs 2252383830 @default.
• W2252383830 citedByCount "20" @default.
• W2252383830 countsByYear W22523838302017 @default.
• W2252383830 countsByYear W22523838302018 @default.
• W2252383830 countsByYear W22523838302019 @default.
• W2252383830 countsByYear W22523838302020 @default.
• W2252383830 countsByYear W22523838302021 @default.
• W2252383830 countsByYear W22523838302022 @default.
• W2252383830 countsByYear W22523838302023 @default.
• W2252383830 crossrefType "journal-article" @default.
• W2252383830 hasAuthorship W2252383830A5003866201 @default.
• W2252383830 hasAuthorship W2252383830A5007553862 @default.
• W2252383830 hasAuthorship W2252383830A5062225954 @default.
• W2252383830 hasAuthorship W2252383830A5072844265 @default.
• W2252383830 hasConcept C10515644 @default.
• W2252383830 hasConcept C126322002 @default.
• W2252383830 hasConcept C136948725 @default.
• W2252383830 hasConcept C141071460 @default.
• W2252383830 hasConcept C143998085 @default.
• W2252383830 hasConcept C207103383 @default.
• W2252383830 hasConcept C2776252253 @default.
• W2252383830 hasConcept C2776914184 @default.
• W2252383830 hasConcept C2778629024 @default.
• W2252383830 hasConcept C3019894029 @default.
• W2252383830 hasConcept C38180746 @default.
• W2252383830 hasConcept C44249647 @default.
• W2252383830 hasConcept C50382708 @default.
• W2252383830 hasConcept C71924100 @default.
• W2252383830 hasConcept C90924648 @default.
• W2252383830 hasConcept C95190672 @default.
• W2252383830 hasConceptScore W2252383830C10515644 @default.
• W2252383830 hasConceptScore W2252383830C126322002 @default.
• W2252383830 hasConceptScore W2252383830C136948725 @default.
• W2252383830 hasConceptScore W2252383830C141071460 @default.
• W2252383830 hasConceptScore W2252383830C143998085 @default.
• W2252383830 hasConceptScore W2252383830C207103383 @default.
• W2252383830 hasConceptScore W2252383830C2776252253 @default.
• W2252383830 hasConceptScore W2252383830C2776914184 @default.
• W2252383830 hasConceptScore W2252383830C2778629024 @default.
• W2252383830 hasConceptScore W2252383830C3019894029 @default.
• W2252383830 hasConceptScore W2252383830C38180746 @default.
• W2252383830 hasConceptScore W2252383830C44249647 @default.

• next